Low density lipoprotein delays clearance of triglyceride-rich lipoprotein by human subcutaneous adipose tissue

Journal of Lipid Research

Volumn 54, Issue 5, 2013, Pages 1466-1476

  Bissonnette, Simon ^a,b   Salem, Huda ^a,b   Wassef, Hanny ^b,c   Saint Pierre, Nathalie ^a,b   Tardif, Annie ^b   Baass, Alexis ^b,c   Dufour, Robert ^a,b   Faraj, May ^a,b,d  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d Montreal Diabetes Research Center MDRC   (Canada)

Author keywords

Apolipoprotein B100; Apolipoprotein B48; Dietary triglyceride clearance; Dyslipidemia; HyperapoB

Indexed keywords

APOLIPOPROTEIN B; CARBON 13; FATTY ACID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TRIOLEIN; TRITIUM; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LIPID METABOLISM; LIPID OXIDATION; LIPID STORAGE; OBESITY; PLASMA CLEARANCE; POSTMENOPAUSE; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN HYDROLYSIS; SUBCUTANEOUS FAT; WHITE ADIPOSE TISSUE;

ADULT; APOLIPOPROTEINS B; DIET, HIGH-FAT; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MIDDLE AGED; OBESITY; SUBCUTANEOUS FAT; TRIGLYCERIDES;

EID: 84876784103     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P023176     Document Type: Article

References (67)

1. Nordestgaard B. G., M. Benn, P. Schnohr, and A. Tybjaerg-Hansen. 2007. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 298 : 299-308.
2. Samra, J. S., M. L. Clark, S. M. Humphreys, I. A. Macdonald, and K. N. Frayn. 1996. Regulation of lipid metabolism in adipose tissue during early starvation. Am. J. Physiol. 271 : E541-E546.
3. Frayn, K. N., S. W. Coppack, B. A. Fielding, and S. M. Humphreys. 1995. Coordinated regulation of hormone-sensitive lipase and lipoprotein lipase in human adipose tissue in vivo : Implications for the control of fat storage and fat mobilization. Adv. Enzyme Regul. 35 : 163-178.
4. Bickerton, A. S. T., R. Roberts, B. A. Fielding, L. Hodson, E. E. Blaak, A. J. M. Wagenmakers, M. Gilbert, F. Karpe, and K. N. Frayn. 2007. Preferential uptake of dietary fatty acids in adipose tissue and muscle in the postprandial period. Diabetes. 56 : 168-176.
5. Evans, K., G. C. Burdge, S. A. Wootton, M. L. Clark, and K. N. Frayn. 2002. Regulation of dietary fatty acid entrapment in subcutaneous adipose tissue and skeletal muscle. Diabetes. 51 : 2684-2690.
6. Faraj, M., H. L. Lu, and K. Cianflone. 2004. Diabetes, lipids, and adipocyte secretagogues. Biochem. Cell Biol. 82 : 170-190.
7. Carpentier, A., S. D. Mittelman, R. N. Bergman, A. Giacca, and G. F. Lewis. 1999. Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am. J. Physiol. 276 : E1055-E1066.
8. Lewis, G. F., A. Carpentier, K. Adeli, and A. Giacca. 2002. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev. 23 : 201-229.
9. Sniderman, A. D., K. Cianflone, and K. Frayn. 1997. The pathogenetic role of impaired fatty acid trapping by adipocytes in generating the pleiotropic features of hyperapoB. Diabetologia. 40 : S152-S154.
10. Zhang, Y. L., A. Hernandez-Ono, C. Ko, K. Yasunaga, L. S. Huang, and H. N. Ginsberg. 2004. Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles. J. Biol. Chem. 279 : 19362-19374.
11. Lewis, G. F. 1997. Fatty acid regulation of very low density lipoprotein production. Curr. Opin. Lipidol. 8 : 146-153.
12. Lewis, G. F., K. D. Uffelman, L. W. Szeto, and G. Steiner. 1993. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes. 42 : 833-842.
13. Malmström, R., C. J. Packard, M. Caslake, D. Bedford, P. Stewart, H. Yki-Jarvinen, J. Shepherd, and M. R. Taskinen. 1997. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia. 40 : 454-462.
14. Ginsberg, H. N., Y. Zhang, and A. Hernandez-Ono. 2005. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch. Med. Res. 36 : 232-240.
15. Sniderman, A., S. Shapiro, D. Marpole, B. Skinner, B. Teng, and P. O. Kwiterovich, Jr. 1980. Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc. Natl. Acad. Sci. USA. 77 : 604-608.
16. Sacks, F. M. 2006. The apolipoprotein story. Atheroscler. Suppl. 7 : 23-27.
17. Yost, T. J., K. K. Froyd, D. R. Jensen, and R. H. Eckel. 1995. Change in skeletal muscle lipoprotein lipase activity in response to insulin/glucose in non-insulin-dependent diabetes mellitus. Metabolism. 44 : 786-790.
18. Frayn, K. N., S. M. Humphreys, and S. W. Coppack. 1996. Net carbon flux across subcutaneous adipose tissue after a standard meal in normal-weight and insulin-resistant obese subjects. Int. J. Obes. Relat. Metab. Disord. 20 : 795-800.
19. de Graaf, J., M. Veerkamp, and A. F. H. Stalenhoef. 2002. Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids. J. R. Soc. Med. 95 : 46-53.
20. Arner, P. 1997. Is familial combined hyperlipidaemia a genetic disorder of adipose tissue? Curr. Opin. Lipidol. 8 : 89-94.
21. Kuniyasu, A., S. Hayashi, and H. Nakayama. 2002. Adipocytes recognize and degrade oxidized low density lipoprotein through CD36. Biochem. Biophys. Res. Commun. 295 : 319-323.
22. Masella, R., R. Vari, M. D'Archivio, C. Santangelo, B. Scazzocchio, M. T. Maggiorella, L. Sernicola, F. Titti, M. Sanchez, U. Di Mario, et al. 2006. Oxidised LDL modulate adipogenesis in 3T3-L1 preadipocytes by affecting the balance between cell proliferation and differentiation. FEBS Lett. 580 : 2421-2429.
23. D'Archivio, M., B. Scazzocchio, C. Filesi, R. Vari, M. T. Maggiorella, L. Sernicola, C. Santangelo, C. Giovannini, and R. Masella. 2008. Oxidised LDL up-regulate CD36 expression by the Nrf2 pathway in 3T3-L1 preadipocytes. FEBS Lett. 582 : 2291-2298.
24. Cianflone, K., M. Bilodeau, J. Davignon, and A. D. Sniderman. 1990. Modulation of chylomicron remnant metabolism by an HMG CoA reductase inhibitor. Metabolism. 39 : 274-280.
25. Cabezas, M. C., T. W. de Bruin, H. Jansen, L. A. Kock, W. Kortlandt, and D. W. Erkelens. 1993. Impaired chylomicron remnant clearance in familial combined hyperlipidemia. Arterioscler. Thromb. 13 : 804-814.
26. Bredie, S. J., T. W. de Bruin, P. N. Demacker, J. J. Kastelein, and A. F. Stalenhoef. 1995. Comparison of gemfi brozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability. Am. J. Cardiol. 75 : 348-353.
27. Castro Cabezas, M., C. Verseyden, S. Meijssen, H. Jansen, and D. W. Erkelens. 2004. Effects of atorvastatin on the clearance of triglyceride-rich lipoproteins in familial combined hyperlipidemia. J. Clin. Endocrinol. Metab. 89 : 5972-5980.
28. Genest, J., R. McPherson, J. Frohlich, T. Anderson, N. Campbell, A. Carpentier, P. Couture, R. Dufour, G. Fodor, G. Francis, et al. 2009. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations. Can. J. Cardiol. 25 : 567-579.
29. Weinsier, R. L., T. R. Nagy, G. R. Hunter, B. E. Darnell, D. D. Hensrud, and H. L. Weiss. 2000. Do adaptive changes in metabolic rate favor weight regain in weight-reduced individuals? An examination of the set-point theory. Am. J. Clin. Nutr. 72 : 1088-1094.
30. Faraj, M., L. Messier, J. P. Bastard, A. Tardif, A. Godbout, D. Prud'homme, and R. Rabasa-Lhoret. 2006. Apolipoprotein B: A predictor of inflammatory status in postmenopausal overweight and obese women. Diabetologia. 49 : 1637-1646.
31. Faraj, M., M-E. Lavoie, L. Messier, J. P. Bastard, and D. Prud'homme. 2010. Reduction in serum apoB is associated with reduced inflammation and insulin resistance in post-menopausal women: A MONET study. Atherosclerosis. 211 : 682-688.
32. Cunningham, J. J. 1990. Calculation of energy expenditure from indirect calorimetry: Assessment of the Weir equation. Nutrition. 6 : 222-223.
33. Faraj, M., P. Jones, A. D. Sniderman, and K. Cianflone. 2001. Enhanced dietary fat clearance in post-obese women. J. Lipid Res. 42 : 571-580.
34. Schectman, G., M. Patsches, and E. A. Sasse. 1996. Variability in cholesterol measurements: Comparison of calculated and direct LDL cholesterol determinations. Clin. Chem. 42 : 732-737.
35. Reyes-Soffer, G., S. Holleran, W. Karmally, C. I. Ngai, N. T. Chen, M. Torres, R. Ramakrishnan, W. S. Blaner, L. Berglund, H. N. Ginsberg, et al. 2009. Measures of postprandial lipoproteins are not associated with coronary artery disease in patients with type 2 diabetes mellitus. J. Lipid Res. 50 : 1901-1909.
36. Wassef, H., H. Salem, S. Bissonnette, A. Baass, R. Dufour, J. Davignon, and M. Faraj. 2012. White adipose tissue-apoC-I secretion; relation to delayed plasma clearance of dietary fat in humans. Arterioscler. Thromb. Vasc. Biol. 32 : 2785-2793.
37. Faraj, M., G. Beauregard, E. Loizon, M. Moldes, K. Clément, Y. Tahiri, K. Cianflone, H. Vidal, and R. Rabasa-Lhoret. 2006. Insulin regulation of gene expression and concentrations of white adipose tissue-derived proteins in vivo in healthy men: Relation to adiponutrin. J. Endocrinol. 191 : 427-435.
38. Moldes, M., G. Beauregard, M. Faraj, N. Peretti, P. H. Ducluzeau, M. Laville, R. Rabasa-Lhoret, H. Vidal, and K. Clément. 2006. Adiponutrin gene is regulated by insulin and glucose in human adipose tissue. Eur. J. Endocrinol. 2006 : 461-468.
39. Binnert, C., M. Laville, C. Pachiaudi, V. Rigalleau, and M. Beylot. 1995. Use of gas chromatography/isotope ratio-mass spectrometry to study triglyceride metabolism in humans. Lipids. 30 : 869-873.
40. Binnert, C., C. Pachiaudi, M. Beylot, M. Croset, R. Cohen, J. P. Riou, and M. Laville. 1996. Metabolic fate of an oral long-chain triglyceride load in humans. Am. J. Physiol. 270 : E445-E450.
41. Knuth, N. D., D. B. Remias, and J. F. Horowitz. 2008. Adding carbohydrate to a high-fat meal blunts postprandial lipemia in women and reduces meal-derived fatty acids in systemic circulation. Appl. Physiol. Nutr. Metab. 33 : 315-325.
42. Vandermeersch, A., S. Ameye, D. Puype, D. Petitjean, M. De Buyzere, and M. R. Langlois. 2010. Estimation of the low-density lipoprotein (LDL) subclass phenotype using a direct, automated assay of small dense LDL-cholesterol without sample pretreatment. Clin. Chim. Acta. 411 : 1361-1366.
43. Wassef, H., L. Bernier, J. Davignon, and J. S. Cohn. 2004. Synthesis and secretion of apoC-I and apoE during maturation of human SW872 liposarcoma cells. J. Nutr. 134 : 2935-2941.
44. Faraj, M., A. Sniderman, and K. Cianflone. 2004. ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes. J. Lipid Res. 45 : 657-666.
45. Faraj, M., and K. Cianflone. 2004. Differential regulation of fatty acid trapping in mouse adipose tissue and muscle by ASP. Am. J. Physiol. Endocrinol. Metab. 287 : E150-E159.
46. Ginsberg, H. N. 1998. Lipoprotein physiology. Endocrinol. Metab. Clin. North Am. 27 : 503-519.
47. Gustafsson, M., M. Levin, K. Skalen, J. Perman, V. Friden, P. Jirholt, S. O. Olofsson, S. Fazio, M. F. Linton, C. F. Semenkovich, et al. 2007. Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: Evidence for a role of lipoprotein lipase. Circ. Res. 101 : 777-783.
48. Boren, J., A. Lookene, E. Makoveichuk, S. Xiang, M. Gustafsson, H. Liu, P. Talmud, and G. Olivecrona. 2001. Binding of low density lipoproteins to lipoprotein lipase is dependent on lipids but not on apolipoprotein B. J. Biol. Chem. 276 : 26916-26922.
49. Williams, K. J., and K. Chen. 2010. Recent insights into factors affecting remnant lipoprotein uptake. Curr. Opin. Lipidol. 21 : 218-228.
50. Teng, B., A. Forse, M. A. Rodriguez, and A. D. Sniderman. 1988. Adipose tissue glyceride synthesis in patients with hyperapobetalipoproteinemia. Can. J. Physiol. Pharmacol. 66 : 239-242.
51. Arner, P., S. Bernard, M. Salehpour, G. Possnert, J. Liebl, P. Steier, B. A. Buchholz, M. Eriksson, E. Arner, H. Hauner, et al. 2011. Dynamics of human adipose lipid turnover in health and metabolic disease. Nature. 478 : 110-113.
52. Wilsie, L. C/, S. Chanchani, D. Navaratna, and R. A. Orlando. 2005. Cell surface heparan sulfate proteoglycans contribute to intracellular lipid accumulation in adipocytes. Lipids Health Dis. 4 : 2.
53. Stanton, L. A., M. van de Venter, and W. Oelofsen. 1999. Interaction of plasma lipoprotein subfractions with differentiating 3T3-L1 and human mammary preadipocytes in culture. J. Cell. Biochem. 74 : 181-193.
54. Fredrickson, D. S., and R. Lee. 1965. A system for phenotyping hyperlipoproteinemia. Circulation. 31 : 321-327.
55. Skogsberg, J., A. Dicker, M. Ryden, G. Astrom, R. Nilsson, H. Bhuiyan, S. Vitols, A. Mairal, D. Langin, P. Alberts, et al. 2008. ApoB100-LDL acts as a metabolic signal from liver to peripheral fat causing inhibition of lipolysis in adipocytes. PLoS ONE. 3 : E3771.
56. Wang, Z., Z. Ying, A. Bosy-Westphal, J. Zhang, M. Heller, W. Later, S. B. Heymsfield, and M. J. Muller. 2012. Evaluation of specific metabolic rates of major organs and tissues: Comparison between nonobese and obese women. Obesity (Silver Spring). 20 : 95-100.
57. Benítez, S., J. L. Sanchez-Quesada, L. Lucero, R. Arcelus, V. Ribas, O. Jorba, A. Castellvi, E. Alonso, F. Blanco-Vaca, and J. Ordonez-Llanos. 2002. Changes in low-density lipoprotein electronegativity and oxidizability after aerobic exercise are related to the increase in associated non-esterified fatty acids. Atherosclerosis. 160 : 223-232.
58. Benítez, S., V. Villegas, C. Bancells, O. Jorba, F. Gonzalez-Sastre, J. Ordonez-Llanos, and J. L. Sanchez-Quesada. 2004. Impaired binding affinity of electronegative low-density lipoprotein (LDL) to the LDL receptor is related to nonesterified fatty acids and lysophosphatidylcholine content. Biochemistry. 43 : 15863-15872.
59. Benítez, S., M. Camacho, R. Arcelus, S. Vila, C. Bancells, J. Ordonez-Llanos, and J. L. Sanchez-Quesada. 2004. Increased lysophosphatidylcholine and non-esterified fatty acid content in LDL induces chemokine release in endothelial cells: Relationship with electronegative LDL. Atherosclerosis. 177 : 299-305.
60. Mello, A. P. Q., I. T. da Silva, D. S. P. Abdalla, and N. R. T. Damasceno. 2011. Electronegative low-density lipoprotein: Origin and impact on health and disease. Atherosclerosis. 215 : 257-265.
61. Posner, I., and J. DeSanctis. 1987. The effects of bovine serum albumin and oleic acid on rat pancreatic lipase and bovine milk lipoprotein lipase. Comp. Biochem. Physiol. B. 87 : 137-141.
62. Posner, I., and J. DeSanctis. 1987. Kinetics of product inhibition and mechanisms of lipoprotein lipase activation by apolipoprotein C-II. Biochemistry. 26 : 3711-3717.
63. Amri, E. Z., L. Teboul, C. Vannier, P. A. Grimaldi, and G. Ailhaud. 1996. Fatty acids regulate the expression of lipoprotein lipase gene and activity in preadipose and adipose cells. Biochem. J. 314 : 541-546.
64. Saxena, U., and I. J. Goldberg. 1990. Interaction of lipoprotein lipase with glycosaminoglycans and apolipoproteins C-II: Effects of free fatty acids. Biochim. Biophys. Acta. 1043 : 161-168.
65. Saxena, U., L. D. Witte, and I. J. Goldberg. 1989. Release of endothelial lipoprotein lipase by plasma lipoproteins and free fatty acids. J. Biol. Chem. 264 : 4349-4355.
66. Olivecrona, T., M. Bergo, M. Hultin, and G. Olivecrona. 1995. Nutritional regulation of lipoprotein lipase. Can. J. Cardiol. 11 : 73G-78G.
67. Sasaki, A., and I. J. Goldberg. 1992. Lipoprotein lipase release from BFC-1 beta adipocytes. Effects of triglyceride-rich lipoproteins and lipolysis products. J. Biol. Chem. 267 : 15198-15204.